Day: July 9, 2021

Agenus Acquires 120 Acres in the Heart of the California Biomanufacturing Center in Vacaville

Agenus Acquires 120 Acres in the Heart of the California Biomanufacturing Center in Vacaville

VACAVILLE, Calif., July 09, 2021 (GLOBE NEWSWIRE) — Agenus Inc. has purchased 120-acres in Vacaville’s California Biomanufacturing Center from housing developer A.G. Spanos, a transaction that represents a major advance in the city’s plans to expand its biotechnology footprint and solidify itself as a global center for biomanufacturing. A.G. Spanos has worked with the City of Vacaville since the launch of the City’s Biotechnology and Advanced Manufacturing initiative in October of 2020. Together they have been working to identify acquirers of the property that would develop biomanufacturing facilities. “Vacaville has been successful in recruiting biomanufacturing over the years and our team at Cushman and Wakefield led by Ryan Hattersley are very proud to represent Agenus. This will be the first biopharma firm to locate here that...

Continue reading

Celldex Therapeutics Presents Positive Data from CDX-0159 Phase 1b Study in Chronic Inducible Urticaria at EAACI 2021

Celldex Therapeutics Presents Positive Data from CDX-0159 Phase 1b Study in Chronic Inducible Urticaria at EAACI 2021

– 95% complete response rate after single dose of CDX-0159 –– Rapid, profound and durable responses offer patients opportunity for quick, lasting, meaningful relief –– Median duration of response 77+ days in Cold Urticaria and 57+ days in Symptomatic Dermographism –– Serum tryptase and skin mast cell depletion mirror clinical activity –– Favorable safety profile –– Company to host webcast conference call on Monday, July 12 at 8:15 a.m. ET – HAMPTON, N.J., July 09, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced updated data from the Company’s ongoing, open label Phase 1b clinical trial of CDX-0159 in patients with antihistamine refractory cold urticaria and symptomatic dermographism, the two most common forms of chronic inducible...

Continue reading

Pharvaris Presents Clinical Data on Oral PHA121 Supporting the Prophylactic Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021

Pharvaris Presents Clinical Data on Oral PHA121 Supporting the Prophylactic Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021

Multiple doses of PHA121 were well-tolerated and showed a favorable pharmacokinetic profile for prophylactic treatment of HAE ZUG, Switzerland, July 10, 2021 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-B2-receptor-mediated indications, today announced the presentation of clinical data supporting the multiple-dose safety and pharmacokinetic (PK) profile of PHA121 (PHA-022121) for the treatment of hereditary angioedema (HAE) at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2021, being held virtually from July 10-16, 2021. The double-blind, randomized, placebo-controlled, multiple ascending dose study included...

Continue reading

Eagle Bulk Shipping Inc. to Issue Second Quarter 2021 Results and Hold Investor Conference Call

Eagle Bulk Shipping Inc. to Issue Second Quarter 2021 Results and Hold Investor Conference Call

STAMFORD, Conn., July 09, 2021 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (Nasdaq: EGLE) will report its financial results for the second quarter ended June 30, 2021, after the close of stock market trading on August 5, 2021. Members of Eagle Bulk’s senior management team will host a teleconference and webcast at 8:00 a.m. ET on Friday, August 6, 2021 to discuss the results. To participate in the teleconference, investors and analysts are invited to call +1 844-282-4411 in the U.S., or +1 512-900-2336 outside of the U.S., and reference participant code 3636539. A simultaneous webcast of the call, including a slide presentation for interested investors and others, may be accessed by visiting http://www.eagleships.com. A replay will be available following the call from 11:00 AM ET on August 6, 2021 until 11:00 AM ET on August 16,...

Continue reading

1844 Announces Second and Final Closing of Non-Brokered Private Placement

1844 Announces Second and Final Closing of Non-Brokered Private Placement

SASKATOON, Saskatchewan, July 09, 2021 (GLOBE NEWSWIRE) — 1844 RESOURCES Inc. (TSX-V:EFF) (the “Company” or “1844”) announces further to its news releases of June 24 and June 30, 2021, that it has closed the second tranche of the non-brokered private placement of common shares in the capital of the Company (the “Shares”) at $0.05 per Share (the “Offering”) by the issuance of 2,500,000 Shares for gross proceeds of $125,000. Management and insider have participated for 8% of the second closing of the Offering. In connection with the second closing of the Offering, the Company didn’t pay any finders’ fees in cash or issued non-transferable share purchase warrants. The securities issued under closing are subject to a four months and a day hold period ending November 10, 2021. The Company has raised a total proceed of $500,000,...

Continue reading

NorthWestern to Host Second Quarter 2021 Financial Results Webinar

NorthWestern to Host Second Quarter 2021 Financial Results Webinar

BUTTE, Mont. and SIOUX FALLS, S.D., July 09, 2021 (GLOBE NEWSWIRE) — NorthWestern Corporation d/b/a NorthWestern Energy (Nasdaq: NWE) today announced that it will host an investor conference call and webinar on Wednesday, July 28, 2021, at 2:30 p.m. Eastern Daylight Time to review its financial results for the quarter ending June 30, 2021. The Company also plans to issue a news release detailing its second quarter financial results the evening of July 27, 2021, after stock market close. To register for the webinar, please visit https://zoom.us/webinar/register/WN_NpOS6ZSzTIaCAYZyWbEwwA or visit the “Presentations and Webcasts” section at www.northwesternenergy.com. Please go to the site at least 15 minutes in advance of the webinar to register. An archived webcast will be available shortly after the event and remain active for...

Continue reading

FutureFuel to Release Second Quarter 2021 Financial Results on August 9, 2021

FutureFuel to Release Second Quarter 2021 Financial Results on August 9, 2021

CLAYTON, Mo., July 09, 2021 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release its second quarter 2021 financial results after market close on Monday, August 9, 2021. About FutureFuel FutureFuel is a leading manufacturer of diversified chemical products, specialty chemical products, and biofuel products. In its chemicals business, FutureFuel manufactures specialty chemicals for specific customers (“custom chemicals”) as well as multi-customer specialty chemicals (“performance chemicals”). FutureFuel’s custom chemicals product portfolio includes proprietary intermediates for major chemical companies and chlorinated polyolefin adhesion promoters and antioxidant precursors for a major chemical company. FutureFuel’s performance...

Continue reading

Vinci Partners’ Private Equity to Sell Domino’s Brasil to BK Brasil (B3:BKBR3) 

Vinci Partners’ Private Equity to Sell Domino’s Brasil to BK Brasil (B3:BKBR3) 

RIO DE JANEIRO, Brazil, July 09, 2021 (GLOBE NEWSWIRE) — Vinci Partners Investments Ltd. (NASDAQ: VINP) (“Vinci Partners,” “we,” “us,” or “our”), the controlling company of a leading alternative investment platform in Brazil, announced today that it has agreed to sell Domino’s Brasil (“Domino’s”, the “Company”) to BK Brasil, the master franchise in Brazil for iconic QSR brands such as Burger King and Popeyes, that since 2017 is listed on the Brazilian Stock Exchange (B3). Domino’s Brasil holds exclusive rights to own, operate and sub-franchise stores under the Domino’s Pizza brand in Brazil. Vinci Capital Partners III (“VCP III”), the third vintage of Vinci Partners’ Private Equity flagship strategy, acquired full ownership of Domino’s in 2018. Since then, VCP III’s management team has supported the Company’s expansion plans, by...

Continue reading

Notice of 2021 Second Quarter Results Conference Call and Webcast for Investors and Analysts

Notice of 2021 Second Quarter Results Conference Call and Webcast for Investors and Analysts

Date: July 29, 2021Time: 1:00 p.m. (Eastern Time) EDMUNDSTON, New Brunswick, July 09, 2021 (GLOBE NEWSWIRE) — Acadian Timber Corp. will release its 2021 second quarter results after market close on July 28, 2021 and will be available on our website at www.acadiantimber.com under “Press Releases”. The release will be followed by a conference call and webcast on Thursday, July 29, 2021 at 1:00 p.m. (Eastern Time) to discuss with members of senior management our financial and operating results. To participate in the second quarter conference call, please dial +1-866-795-3013 toll free in North America (Canada and the USA) or, for overseas calls, +1-409-937-8907 (Conference ID 9763584) at approximately 12:50 p.m. (Eastern Time). The media and investing public may access this conference call via a listen in mode only. For those unable...

Continue reading

Pilgrim’s Pride Corporation to Host Second Quarter 2021 Earnings Call on July 29, 2021

Pilgrim’s Pride Corporation to Host Second Quarter 2021 Earnings Call on July 29, 2021

GREELEY, Colo., July 09, 2021 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) announced today that it will host its second quarter 2021 earnings conference call and webcast on Thursday, July 29, 2021 at 7:00 a.m. MT (9:00 a.m. ET). Prepared remarks regarding the company’s financial and operational results will be followed by a question and answer period with Pilgrim’s executive management team. Investors and analysts may pre-register for the webcast to receive a unique PIN to gain immediate access to the call and bypass the live operator. Pre-registration may be completed at any time, including up to and after the call has begun, by accessing the company’s investor website at https://ir.pilgrims.com in the “Events & Presentations” section. Participants also can register for the conference call and webcast at https://services.choruscall.com/links/ppc210429.html. Participants...

Continue reading